About PhyNexus
PhyNexus is a company based in San Jose (United States) founded in 2002 was acquired by Biotage in December 2018.. PhyNexus offers products and services including Biotage® Initiator+, Biotage® Selekt, and ISOLUTE® SCX-2. PhyNexus operates in a competitive market with competitors including ArcherDX, RareCyte, Sequenta, seqWell and Paragon Genomics, among others.
- Headquarter San Jose, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biotage Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PhyNexus
PhyNexus offers a comprehensive portfolio of products and services, including Biotage® Initiator+, Biotage® Selekt, and ISOLUTE® SCX-2. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Microwave synthesizer for efficient organic chemistry reactions
System for purification in drug discovery processes
Product for solid phase extraction in analytical workflows
Funding Insights of PhyNexus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PhyNexus
PhyNexus has secured backing from 1 investor. Prominent investors backing the company include Biotage. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PhyNexus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PhyNexus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Phynexus Comparisons
Competitors of PhyNexus
PhyNexus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, RareCyte, Sequenta, seqWell and Paragon Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Immuno-sequencing products are developed for disease diagnostics and treatment.
|
|
| domain | founded_year | HQ Location |
NGS-based reagents and kits are supplied for life sciences research.
|
|
| domain | founded_year | HQ Location |
Provider of technologies and solutions genomic research and precision medicine
|
|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about PhyNexus
When was PhyNexus founded?
PhyNexus was founded in 2002.
Where is PhyNexus located?
PhyNexus is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
What does PhyNexus do?
PhyNexus was founded in 2002 in San Jose, United States, within the biotechnology sector. Automated liquid handlers and nucleic acid extractors are produced for molecular biology applications. Operations include plasmid DNA purification kits, affinity columns, specialty resins, gel filtration systems, normal phase columns, and ion exchange columns. Benchtop robotic instruments, such as the Auto plasmid MEA, and semi-automated protein extractors are also manufactured to support research workflows.
Who are the top competitors of PhyNexus?
PhyNexus's top competitors include Neogen, Paragon Genomics and ArcherDX.
What products or services does PhyNexus offer?
PhyNexus offers Biotage® Initiator+, Biotage® Selekt, and ISOLUTE® SCX-2.
Who are PhyNexus's investors?
PhyNexus has 1 investor. Key investors include Biotage.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.